Structural Basis of Tau Interaction With BIN1 and Regulation by Tau Phosphorylation
暂无分享,去创建一个
J. Lambert | I. Landrieu | F. Cantrelle | Hamida Merzougui | Alessia Lasorsa | Idir Malki | E. Boll | Idir Malki
[1] M. Pinard. Structural determinants , 2020, Nationalist Movements Explained.
[2] A. Teleman,et al. Bin1 directly remodels actin dynamics through its BAR domain , 2017, EMBO reports.
[3] J. Lambert,et al. Regulation of the interaction between the neuronal BIN1 isoform 1 and Tau proteins – role of the SH3 domain , 2017, The FEBS journal.
[4] Florent Ubelmann,et al. Bin1 and CD2AP polarise the endocytic generation of beta‐amyloid , 2017, EMBO reports.
[5] P. Verstreken,et al. Loss of Bin1 Promotes the Propagation of Tau Pathology. , 2016, Cell Reports.
[6] P. Permi,et al. Structural Basis of the High Affinity Interaction between the Alphavirus Nonstructural Protein-3 (nsP3) and the SH3 Domain of Amphiphysin-2* , 2016, The Journal of Biological Chemistry.
[7] H. Soininen,et al. Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology , 2016, Molecular Psychiatry.
[8] G C P van Zundert,et al. The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes. , 2016, Journal of molecular biology.
[9] J. Gunawardena,et al. Characterization of Neuronal Tau Protein as a Target of Extracellular Signal-regulated Kinase* , 2016, The Journal of Biological Chemistry.
[10] I. Landrieu,et al. Proline Conformation in a Functional Tau Fragment. , 2016, Journal of molecular biology.
[11] J. Lambert,et al. Tau phosphorylation regulates the interaction between BIN1’s SH3 domain and Tau’s proline-rich domain , 2015, Acta neuropathologica communications.
[12] M. Blackledge,et al. Structural Impact of Tau Phosphorylation at Threonine 231. , 2015, Structure.
[13] K. Ishiguro,et al. Physiological and pathological phosphorylation of tau by Cdk5 , 2014, Front. Mol. Neurosci..
[14] J. Laporte,et al. Amphiphysin 2 (BIN1) in physiology and diseases , 2014, Journal of Molecular Medicine.
[15] Nick C Fox,et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.
[16] M. Owen,et al. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology , 2013, Molecular Psychiatry.
[17] I. Landrieu,et al. Towards understanding the phosphorylation code of tau. , 2012, Biochemical Society transactions.
[18] I. Landrieu,et al. Structural characterization by nuclear magnetic resonance of the impact of phosphorylation in the proline‐rich region of the disordered Tau protein , 2012, Proteins.
[19] T. Sixma,et al. Enabling high-throughput ligation-independent cloning and protein expression for the family of ubiquitin specific proteases. , 2011, Journal of structural biology.
[20] P. Bosco,et al. APOE and Alzheimer disease: a major gene with semi-dominant inheritance , 2011, Molecular Psychiatry.
[21] I. Landrieu,et al. Spectroscopic Studies of GSK3β Phosphorylation of the Neuronal Tau Protein and Its Interaction with the N-terminal Domain of Apolipoprotein E , 2010, The Journal of Biological Chemistry.
[22] L. Buée,et al. NMR spectroscopy of the neuronal tau protein: normal function and implication in Alzheimer's disease. , 2010, Biochemical Society transactions.
[23] Sudha Seshadri,et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. , 2010, JAMA.
[24] L. Kiemeney,et al. Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.
[25] Nick C Fox,et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.
[26] P. Camilli,et al. The BAR Domain Superfamily: Membrane-Molding Macromolecules , 2009, Cell.
[27] H. Braak,et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.
[28] Thomas Szyperski,et al. A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinants. , 2005, Journal of molecular biology.
[29] L. Buée,et al. Regulation of Pin1 peptidyl‐prolyl cis/trans isomerase activity by its WW binding module on a multi‐phosphorylated peptide of Tau protein , 2005, FEBS letters.
[30] Wayne Boucher,et al. The CCPN data model for NMR spectroscopy: Development of a software pipeline , 2005, Proteins.
[31] L. Buée,et al. The peptidyl prolyl cis/trans-isomerase Pin1 recognizes the phospho-Thr212-Pro213 site on Tau. , 2004, Biochemistry.
[32] C. Dominguez,et al. HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. , 2003, Journal of the American Chemical Society.
[33] J. Cho,et al. Glycogen synthase kinase 3beta phosphorylates tau at both primed and unprimed sites. Differential impact on microtubule binding. , 2003, The Journal of biological chemistry.
[34] Julie D. Forman-Kay,et al. Sequential assignment of proline-rich regions in proteins: Application to modular binding domain complexes , 2000, Journal of biomolecular NMR.
[35] Pietro De Camilli,et al. Functional partnership between amphiphysin and dynamin in clathrin-mediated endocytosis , 1999, Nature Cell Biology.
[36] E. Mandelkow,et al. Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. , 1998, European journal of biochemistry.
[37] D. S. Garrett,et al. Solution structure of the 30 kDa N-terminal domain of enzyme I of the Escherichia coli phosphoenolpyruvate:sugar phosphotransferase system by multidimensional NMR. , 1997, Biochemistry.
[38] P. De Camilli,et al. A role of amphiphysin in synaptic vesicle endocytosis suggested by its binding to dynamin in nerve terminals. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[39] S. Grzesiek,et al. Sequential backbone assignment of isotopically enriched proteins in D2O by deuterium-decoupled HA(CA)N and HA(CACO)N , 1995, Journal of biomolecular NMR.
[40] Wendell A. Lim,et al. Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains , 1995, Nature.
[41] S. Schreiber,et al. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. , 1995, Science.
[42] P. Cohen,et al. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. , 1994, The Biochemical journal.
[43] E. Mandelkow,et al. Abnormal Alzheimer‐like phosphorylation of tau‐protein by cyclin‐dependent kinases cdk2 and cdk5 , 1993, FEBS letters.
[44] K. Imahori,et al. Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments , 1993 .
[45] V. Saudek,et al. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions , 1992, Journal of biomolecular NMR.
[46] G. Drewes,et al. Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer‐like state. , 1992, The EMBO journal.
[47] M. Murphy,et al. Bridging integrator 1 (BIN1) protein expression increases in the Alzheimer's disease brain and correlates with neurofibrillary tangle pathology. , 2014, Journal of Alzheimer's disease : JAD.
[48] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[49] P. Afonine,et al. research papers Acta Crystallographica Section D Biological , 2003 .
[50] J. Endicott,et al. Methods for preparation of proteins and protein complexes that regulate the eukaryotic cell cycle for structural studies. , 2005, Methods in molecular biology.
[51] F. García-Sierra,et al. Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer's disease. , 2005, Journal of Alzheimer's disease : JAD.
[52] K. Imahori,et al. Glycogen synthase kinase 3 beta is identical to tau protein kinase I generating several epitopes of paired helical filaments. , 1993, FEBS letters.
[53] W. R. Gowers,et al. Physiological and pathological , 1876 .